...
首页> 外文期刊>Critical reviews in oncology/hematology >The detection and role of lymphatic and blood vessel invasion in predicting survival in patients with node negative operable primary colorectal cancer.
【24h】

The detection and role of lymphatic and blood vessel invasion in predicting survival in patients with node negative operable primary colorectal cancer.

机译:淋巴管和血管浸润的检测及其在预测淋巴结阴性可手术原发性结直肠癌患者生存率中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Although vascular invasion in colorectal cancer has been recognised since 1938, detection methods and results remain inconsistent. Vascular invasion is currently an independent prognostic factor in colorectal cancer influencing disease progression and survival. The vascular system consists of three components, arterial, venous and lymphatic vessels, all of which can be invaded but accurate distinction between the components remains difficult with routine staining techniques. Even though higher detection rates with elastica staining, for large vessel invasion, and recent techniques for immunohistochemistry for small vessel invasion, have been reported, a standardised method of detection has not been agreed upon which is reflected in the variability of published results. As a result of the Bowel Cancer Screening Programme in the UK it will be necessary to attempt to identify and stratify patients better, to be able to handle the stage migration to early node negative colorectal cancer. At present up to a third of patients, with node-negative colorectal cancer on conventional histopathological analysis, ultimately die of recurrent disease. It is therefore important to develop and standardised methods to identify lymphatic and blood vessel invasion which will influence ultimate survival. The present review summarises the current status of detection methods for these components of vascular invasion.
机译:尽管自1938年以来就已认识到大肠癌中的血管浸润,但检测方法和结果仍然不一致。当前,血管浸润是影响疾病进展和生存的大肠癌的独立预后因素。血管系统由动脉,静脉和淋巴管三个部分组成,所有这些都可以被侵入,但是使用常规染色技术仍然很难准确区分这些部分。尽管已经报道了对于较大的血管侵袭,使用弹性蛋白染色的检测率更高,并且对于较小的血管侵袭,采用了免疫组织化学的最新技术,但仍未就检测的标准化方法达成共识,这反映在已发表结果的可变性上。由于英国肠癌筛查计划的结果,有必要尝试更好地识别和分层患者,以便能够处理向早期淋巴结阴性大肠癌的分期迁移。目前,按常规组织病理学分析,多达三分之一的淋巴结阴性大肠癌患者最终死于复发性疾病。因此,重要的是开发和标准化方法以识别会影响最终生存的淋巴和血管浸润。本综述总结了这些血管侵犯成分的检测方法的现状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号